Pfizer’s COVID-19 shot less effective against South African variant: study – National

The coronavirus variant discovered in South Africa can “break through” Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer reviewed. The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, […]

Pfizer, BioNTech ask U.S. to allow COVID-19 vaccine emergency use in adolescents – National

Pfizer Inc and its German partner BioNTech SE on Friday asked U.S. regulators to allow the emergency use of their COVID-19 vaccine in adolescents aged 12 to 15. The vaccine is currently authorized for emergency use in the United States for people aged 16 and up. The companies said on Friday that they requested […]

Some U.S. areas stop using J&J COVID-19 vaccine after ‘adverse reaction’ reports – National

Following the shutdown of a mass vaccination site in Colorado after 11 people reported “adverse reactions” to the Johnson & Johnson COVID-19 jab, a county in North Carolina also paused its use on Thursday. The decision came “out of an abundance of caution,” after some people reported feelings of nausea and dizziness, a senior […]

With COVID-19 variant cases on the rise, what do experts recommend? – National

Just as vaccination drives are picking up steam across Canada, deadlier and possibly more transmissible COVID-19 variants are spiking up infection rates among Canadians. “It’s very concerning,” Dr. Susy Hota, medical director of infection prevention and control at University Health Network, Toronto told Global News Wednesday. The “impact of transmission” when it comes to […]

Pfizer says COVID-19 vaccine protects kids aged 12-15 in trial – National

Pfizer Inc and BioNTech SE said on Wednesday their COVID-19 vaccine was safe and effective and produced robust antibody responses in 12-to 15-year olds, paving the way for them to seek U.S. emergency use authorization in weeks. Pfizer hopes that vaccinations of the group could begin before the next school year, Albert Bourla, Pfizer’s chairman and chief […]

Johnson & Johnson COVID-19 vaccine plant approved in U.S. – National

A large plant being used to manufacture Johnson & Johnson’s COVID-19 vaccine was cleared by U.S. regulators on Tuesday, setting the stage for the weekly U.S. supply to surge more then 20 percent. About 27 million COVID-19 vaccine doses will be allocated to U.S. states and other localities this week, including four million from J&J, White House spokeswoman Jen Psaki […]

European trust in AstraZeneca COVID-19 vaccine plummets after blood clot reports – National

Confidence in the safety of AstraZeneca’s COVID-19 vaccine has taken a big hit in Spain, Germany, France and Italy as reports of rare blood clots have been linked to it and many countries briefly stopped using it, poll data showed on Monday. The polling firm YouGov said it had already found in late February […]

AstraZeneca COVID-19 vaccine has ‘tremendous potential’: WHO – National

The World Health Organization’s vaccine safety panel said on Friday that data from AstraZeneca’s COVID-19 shot do not point to any overall increase in clotting conditions but it would continue to monitor its effects. Read more: Nearly a dozen countries resume AstraZeneca shots after regulators declare it safe “The AstraZeneca COVID-19 vaccine (including Covishield) […]

Britain’s COVID-19 vaccine rollout hit by supply crunch in India – National

Britain will have to slow its COVID-19 vaccine rollout next month due to a supply crunch caused by a delay in a shipment of millions of AstraZeneca shots from India and the need to test the stability of an additional 1.7 million doses. Supply constraints are the biggest threat to Britain’s vaccine rollout – currently the swiftest among the world’s […]

WHO allows Johnson & Johnson vaccine for emergency use – National

The World Health Organization has approved the emergency-use listing of Johnson & Johnson’s COVID-19 vaccine, the U.N. agency said on Friday, broadening access to the shots. It is the third COVID-19 vaccine after those of Pfizer/BioNTech and AstraZeneca to receive backing from the WHO. The listing covers use in all countries and for the […]